- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Cantor Fitzgerald analyst Louise Chen says the drug company's execution has continued to meet or surpass expectations.
Here's what you need to know now.
Seattle Genetics, FibroGen and Sangamo were among the biotech stock movers in premarket trading on June 26.